Written Description and Enablement Requirements For Antibodies By Irving Feit Teva Pharmaceuticals International GmbH v. Eli Lilly and Company U.S. Court of Appeals for the Federal Circuit […]

Why USPTO Should Issue Inherency Guidance Memo By Irving Feit · Law360, April 2, 2024 From time to time, the U.S. Patent and Trademark Office issues guidance memos to […]